Azenta Divests B Medical Systems for $63 Million to Focus on Core Life Sciences Portfolio
核心洞察
Azenta (搜索) has signed a definitive agreement to sell its B Medical Systems (搜索) business to THELEMA S.À R.L. (搜索) for $63 million, with the transaction expected to close by March 31, 2026.
The divestiture represents a strategic portfolio simplification to prioritize Azenta (搜索)'s core capabilities with the highest strategic impact in life sciences solutions.
B Medical Systems (搜索) is a Luxembourg-based global manufacturer and distributor of medical refrigeration devices that will be separated from Azenta (搜索)'s primary cold-chain sample management and multiomics services.
Azenta (搜索), Inc. announced on December 29, 2025, that its affiliate Azenta Germany GmbH has entered into a binding agreement to sell the B Medical Systems (搜索) business to THELEMA S.À R.L. (搜索) for $63 million. The transaction is expected to close on or before March 31, 2026, marking a significant strategic move for the life sciences solutions provider.
Strategic Portfolio Optimization
"The agreement to sell B Medical Systems (搜索) marks a major step forward in simplifying the portfolio to prioritize our core capabilities with the highest strategic impact," said John Marotta, President and CEO of Azenta (搜索). The company plans to deploy proceeds from the sale to strengthen operations and drive long-term profitable value creation for shareholders.
B Medical Systems (搜索) operates as a global manufacturer and distributor of medical refrigeration devices and is based in Luxembourg. The business represents a non-core asset for Azenta (搜索) as the company focuses on its primary life sciences offerings.
Core Business Focus
Azenta (搜索) positions itself as a leading provider of life sciences solutions worldwide, enabling organizations to bring impactful breakthroughs and therapies to market faster. The company's core portfolio includes cold-chain sample management solutions and multiomics services across drug development, clinical research, and advanced cell therapies for pharmaceutical, biotech, academic, and healthcare institutions globally.
The company operates through industry-leading brands including GENEWIZ (搜索), FluidX (搜索), Ziath (搜索), 4titude, Limfinity, Freezer Pro, and Barkey. Azenta (搜索) maintains global operations across North America, Europe, and Asia from its Burlington, Massachusetts headquarters.
Transaction Details
William Blair (搜索) served as exclusive financial advisor for the transaction, while Taylor Wessing (搜索) provided legal counsel to Azenta (搜索). The $63 million purchase price reflects the strategic value of the medical refrigeration business to the acquiring entity while allowing Azenta to focus resources on its core competencies in life sciences solutions.